Position in RCEL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$615,085
+$293,611 QoQ
Shares Held
148,931
+71.4% QoQ
Ownership
0.482%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 73 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 4%
Shared 0%
None 96%
Common Shares in RCEL Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026NewEdge Advisors, LLC holds $143,490,037 across 42 Medical Devices names. RCEL ranks #12 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GEHC |
GE HealthCare Technologies Inc.
|
1,318,329 | $84,386,239 | |
| 2 | ABT |
Abbott Laboratories
|
227,122 | $20,609,050 | |
| 3 | MDT |
Medtronic plc
|
148,741 | $11,636,008 | |
| 4 | SYK |
Stryker Corp
|
31,073 | $9,783,023 | |
| 5 | GMED |
Globus Medical Inc
|
39,810 | $3,145,388 | |
| 6 | BSX |
Boston Scientific Corp
|
67,588 | $2,884,655 | |
| 7 | IRMD |
Iradimed Corp
|
25,254 | $2,413,272 | |
| 8 | DXCM |
Dexcom Inc
|
29,455 | $1,983,794 |
All Filings in RCEL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $615,085 | 148,931 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $321,474 | 86,885 | Shares | Sole | 2026-06-03 | |
| 2025-12-31 | $3,450 | 1,000 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $5,110 | 1,000 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $5,290 | 1,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,140 | 1,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $12,800 | 1,000 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||